clinical trial · NCT07744828
A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants
Healthy VolunteersDRL_AB
brief summary
The purpose of this study is to assess the PK comparability and compare safety and tolerability of DRL\_AB administered via an auto injector (AI) or prefilled syringe (PFS) in healthy male participants.
started
Aug 19, 2026
primary completion
Dec 29, 2026
completion
Dec 29, 2026
last updated
Aug 4, 2026
official title
A Single-dose, Randomized, Open-label, Parallel-arm, Comparative Pharmacokinetic and Safety Study of Proposed Abatacept Biosimilar DRL_AB Administered by the Subcutaneous Route Via Autoinjector or Prefilled Syringe to Normal, Healthy, Male Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol